Insider · CIK 0001639012
Gibbs Thomas Edward
Reports to the SEC for 2 companies · WASHINGTON, DC
Transactions
9
Companies
2
Filings
8
CIK
0001639012
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2019-06-28 | OptiNose, Inc.A Award | +$15.6K |
| 2019-04-17 | OptiNose, Inc.Restricted Stock UnitsA Award | — |
| 2019-03-07 | OptiNose, Inc.S Sale | −$16.5K |
| 2019-02-28 | OptiNose, Inc.Stock Option (Right to Buy)A Award | — |
| 2018-12-31 | OptiNose, Inc.A Award | +$3,311.62 |
| 2018-08-15 | OptiNose, Inc.P Purchase | +$25.4K |
| 2017-10-12 | OptiNose, Inc.Stock Option (Right to Buy)A Award | — |
| 2015-04-20 | VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)A Award | — |
| 2015-04-20 | VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitsA Award | — |
Recent filings
- 4Gibbs Thomas Edward0001494650-19-000065SEC(opens sec.gov)
- 4Gibbs Thomas Edward0001494650-19-000035SEC(opens sec.gov)
- 4Gibbs Thomas Edward0001494650-19-000033SEC(opens sec.gov)
- 4Gibbs Thomas Edward0001494650-19-000031SEC(opens sec.gov)
- 5Gibbs Thomas Edward0001494650-19-000007SEC(opens sec.gov)
- 4Gibbs Thomas Edward0001494650-18-000091SEC(opens sec.gov)
- 4Gibbs Thomas Edward0001104659-17-062329SEC(opens sec.gov)
- 4Vanda Pharmaceuticals Inc.0001209191-15-035329SEC(opens sec.gov)
Companies
Address
2200 PENNSYLVANIA AVE NW
WASHINGTON, DC, 20037